Since 2008, ViruSure’s in vitro and molecular laboratories moved into the Tech Gate Science and Technology Park in Vienna, Austria. In 2017, we opened our new state-of-the-art in vivo facility in Vienna.
Since the company has been founded Dr. Bailey is our CEO and Operations Director. Our growing team offers a wide range of biosafety testing services and a breadth of expertise to customers in Europe, the US, and Asia to ensure you meet all relevant pathogen safety testing requirements.
We focus on cell line characterization, mycoplasma testing, mycoplasma PCR, prion validation, prion testing, tumorigenicity testing, oncogenicity study, cell identity testing, mycobacteria testing, cell bank testing and virus bank testing. Just to name a few of our big portfolio
In 2019, ViruSure was acquired by Asahi Kasei Medical and remains a separate business unit of its Bioprocess Division.